Inventor
NADLER JERRY L
US15 patents
⚠️ This page may combine multiple inventors who share the name “NADLER JERRY L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOPE CITY
6 patentsUS6485976B1Nov 26, 2002
Use of adeno-associated virus (AAV) to deliver genes
HOPE CITY19 citations85
US6693106B2Feb 17, 2004
Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE's)
HOPE CITY15 citations83
US6893829B2May 17, 2005
Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
HOPE CITY10 citations71
US6191169B1Feb 20, 2001
Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
HOPE CITY9 citations71
US6046224AApr 4, 2000
12 (S)--hete receptor blockers
HOPE CITY10 citations66
US6486181B1Nov 26, 2002
Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
HOPE CITY3 citations60
EASTERN VIRGINIA MEDICAL SCHOOL
3 patentsUS10266488B2Apr 23, 2019
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
EASTERN VIRGINIA MEDICAL SCHOOL3 citations69
US11274077B2Mar 15, 2022
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
EASTERN VIRGINIA MEDICAL SCHOOL1 citations59
US10752581B2Aug 25, 2020
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
EASTERN VIRGINIA MEDICAL SCHOOL1 citations59